Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Overview

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Full Title of Study: “Evaluation of Role of Ultrasound TA,TV,TP in Diagnosis of Placenta Previa and MAP(Morbidly Adherent Placenta )”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 10, 2019

Detailed Description

The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.

Arms, Groups and Cohorts

  • normal placenta
    • TA , TV ,TP us
  • placenta previa and MAP
    • TA,TV.TP us

Clinical Trial Outcome Measures

Primary Measures

  • number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US
    • Time Frame: within 6 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • pregnant ladies with previous cesarean sections – GA above 34 weeks Exclusion Criteria:

  • Primigravida patients – GA below 34 weeks

Gender Eligibility: Female

pregnant females with GA above 34 weeks

Minimum Age: 20 Years

Maximum Age: 43 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Aljazeera Hospital
  • Collaborator
    • Cairo University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mahmoud Alalfy, Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital – Aljazeera Hospital
  • Overall Official(s)
    • Mahmoud Alalfy, Principal Investigator, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.